Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study

NCT02928549 | Completed

• 1 other identifier: 16-1378
• Study Type: observational
• Target: 24
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to explore the experiences of Black women who receive care for ovarian cancer at Memorial Sloan Kettering Cancer Center, or "MSK" for short. The study consists of interviews with Black women who recently obtained some part of their ovarian cancer care at MSK.

Conditions

Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer

Keywords

interviews; 16-1378

Outcome Measures

Primary Outcomes (1)

• accessing care

  The study team will review and code the interview transcripts through a process of independent and collaborative thematic content analysis,\[15-18\] using ATLAS.ti (a qualitative data analysis software package) to facilitate the analysis process.

  1 year

Study Arms (1)

Black Women with Cancer

In this formative qualitative research study we aim to use one-on-one semi-structured interviews with Black women diagnosed with ovarian cancer to learn about their experiences and their journey to accessing care at a high-volume ovarian cancer care center (HVC).

Behavioral: semi-structured interviews

Interventions

semi-structured interviews BEHAVIORAL

Black Women with Cancer

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

MSK Gynecology clinic

You may qualify if:

• Participant must have been diagnosed with ovarian, fallopian tube or primary peritoneal cancer and treated by an MSK physician.
• Participants must be able to provide verbal informed consent.
• Participants must be 18 years of age or older.
• Participants must self-identify as Black/African American.
• Participant must be able to understand and speak in English

You may not qualify if:

• Inability or refusal to identify race/ethnicity.
• Presence or development of a physical, cognitive or psychiatric deficit resulting in an inability to provide meaningful informed consent or to understand the study or complete the interview.

Sponsors & Collaborators

• Memorial Sloan Kettering Cancer Center: lead

Study Sites (1)

Memorial Sloan-Kettering Cancer Center

New York, New York, 10021, United States

Location

Related Links

• Memorial Sloan Kettering Cancer Center

MeSH Terms

Conditions

Ovarian Neoplasms; Fallopian Tube Neoplasms

Condition Hierarchy (Ancestors)

Endocrine Gland Neoplasms; Neoplasms by Site; Neoplasms; Ovarian Diseases; Adnexal Diseases; Genital Diseases, Female; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Genital Neoplasms, Female; Urogenital Neoplasms; Genital Diseases; Endocrine System Diseases; Gonadal Disorders; Fallopian Tube Diseases

Study Officials

• Kara Long-Roche, MD

  Memorial Sloan Kettering Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 6, 2016
• First Posted: October 10, 2016
• Study Start: September 22, 2016
• Primary Completion: August 26, 2019
• Study Completion: August 26, 2019
• Last Updated: August 28, 2019

Record last verified: 2019-08

Locations

US (1)